Acusphere, Inc. is a pharmaceutical company, which engages in the development of drugs and formulations of existing drugs using proprietary micro particle technology. The company is headquartered in Lexington, Massachusetts. The company went IPO on 2003-10-08. The firm is focused on the development of Imagify, which contains Perflubutane Polymer Microspheres for injectable suspension. The firm's product Imagify is a cardiovascular drug for the detection of coronary artery disease (CAD). Imagify injectable suspension consists of porous, synthetic polymer microspheres containing gas that are administered intravenously and act as tracers of blood flow or perfusion. The firm has submitted the Marketing Authorization Application (MAA) for its lead product candidate, Imagify lyophilisate for dispersion for injection with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union (EU).
Follow-Up Questions
Acusphere Inc (ACUS) 的市盈率是多少？
Acusphere Inc 的市盈率是 0
Acusphere Inc 的 CEO 是谁？
Mr. Mark Leuchtenberger 是 Acusphere Inc 的 President，自 2013 加入公司。
ACUS 股票的价格表现如何？
ACUS 的当前价格为 $0，在上个交易日 decreased 了 0%。
Acusphere Inc 的主要业务主题或行业是什么？
Acusphere Inc 属于 Pharmaceuticals 行业，该板块是 Health Care
